Ishara Investments’s Ligand Pharmaceuticals LGND Stock Holding History

Ishara Investments’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-8,200	Closed	-$1.64M	–	49
2026 Q1	$1.64M	Buy	+8,200	New	+$1.62M	1.55%	26

Other funds holding LGND

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ishara Investments's LGND Position: Q2 2026 in Review

Ishara Investments sold out of Ligand Pharmaceuticals (LGND) in Q2 2026, closing a stake of 8,200 shares — an estimated $1.64M sold.

Ishara Investments first reported a position in LGND in Q1 2026 and held it in 1 quarter. The position peaked at $1.64M in Q1 2026. 415 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

Ishara Investments reported no remaining Ligand Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Ishara Investments sold 8,200 Ligand Pharmaceuticals shares in Q2 2026, an estimated $1.64M.
Ishara Investments first reported a position in Ligand Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Ishara Investments's Ligand Pharmaceuticals position peaked at $1.64M in Q1 2026.
415 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Ishara Investments's 13F filing for Q2 2026, filed 14 Aug 2026.